Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance

✍ Scribed by Herbert Schuster; Björn Fagerberg; Siôn Edwards; Tamas Halmos; Jerzy Lopatynski; Steen Stender; Grethe Stoa Birketvedt; Serena Tonstad; Ingrid Gause-Nilsson; Sigrún Halldórsdóttir; K. Peter Öhman

• Book ID: 118421737
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 152 KB
• Volume: 197
• Category: Article
• ISSN: 0021-9150
• DOI: 10.1016/j.atherosclerosis.2007.05.029